The biopharmaceutical industry is experiencing a significant shift towards outsourcing manufacturing. The global Biopharmaceutical Contract Manufacturing Market is projected to surge at a staggering Compound Annual Growth Rate (CAGR) of 8.8%, according to a recent market analysis. This translates to a market value skyrocketing from USD 10.7 billion in 2024 to a remarkable USD 25.1 …
Tag Archives: Biopharmaceutical Contract Manufacturing
Global Biopharmaceutical Contract Manufacturing Industry Poised for 8.8% CAGR, Aims for US$ 25.1 Billion Market Triumph by 2034 | FMI Reports
The Global Biopharmaceutical Contract Manufacturing Industry is poised for remarkable expansion, anticipating a Compound Annual Growth Rate (CAGR) of 8.8% throughout the projected period. According to the latest insights, the market’s value is forecasted to surge from US$ 10.7 billion in 2024 to an impressive US$ 25.1 billion by the year 2034. This projection reflects …
Biopharmaceutical Contract Manufacturing Industry’s 10.5% CAGR Towards US$18.7 Billion in 2029 | FMI
The Global Biopharmaceutical Contract Manufacturing Industry, valued at approximately US$ 9.3 billion in 2022, is set to experience robust growth at a Compound Annual Growth Rate (CAGR) of 10.5%. It is expected to reach a staggering US$ 18.7 billion by 2029. This meteoric rise reflects the growing trend among pharmaceutical companies to outsource their biopharmaceutical …